Thin line between drugs and cosmetics; well-informed policy and rules need of the hour: Shraddha Srivastava, ADC(I), CDSCO

Thin line between drugs and cosmetics; well-informed policy and rules need of the hour: Shraddha Srivastava, ADC(I), CDSCO
Representation purpose only

Ms Shraddha Srivastava, Assistant Drugs Controller (I), Central Drugs Standard Control Organization (CDSCO), stated today that as cosmetics become a part of daily life for all segments of society, regardless of age, gender, or location, it becomes necessary to establish regulations that benefit both consumers and manufacturers.

Ms Srivastava stated at the session on Opportunities to Develop New Indian Cosmetics Regulations - Steps Toward International Harmonization at FICCI MASSMERIZE- FMCG & Retail RESILIENCE that there is a fine line between drugs and cosmetics under government regulations. As a result, well-informed policy and regulatory frameworks are critical, whether for industry, consumers, or the government.

Additionally, Ms Srivastava stated that the CDSCO updated and published the Cosmetics Rules 2020 under the Drugs and Cosmetics Act 1940 following years of thought and consultation with numerous stakeholders, consumers, and industry on a national and international level. "It is the outcome of the cosmetics industry's objectives and requirements, as well as those of customers," she explained. Additionally, she stated that the CDSCO attempted to protect the cosmetics industry's business continuity throughout the epidemic.

Mr Narender Ahooja Vivek, State Drug Controller of the Food and Drug Administration (FDA), Government of Haryana, stated during the occasion, "The most critical stakeholder in the entire chain is not the maker, the owner, or even the regulator; it is the product's end user or customer. The end user is not always aware of the product's safety or efficacy. As a result, the entire burden of producing effective and safe cosmetics rests with regulators, manufacturers, and the marketer - the owner of the brand name."

Additionally, Mr Vivek stated that cosmetics are based on four pillars: cleanliness, beautification, enhancing beauty, and altering appearances. "No cosmetic should make a claim that deviates from these four pillars and enters the realm of pharmaceuticals. Cosmetics makers should avoid making extravagant marketing promises, as these are forbidden by the CDSCO's standards "'He stated.

Dr Sonal Shidhore, Director, Regulatory Affairs, Johnson & Johnson Pvt Ltd, stated that while the beauty sector has numerous problems, the goal is to supply high-quality goods to end users.

Mr Sumeet S Jaiswal, Head of Regulatory & Business Affairs, Oriflame South Asia, stated that the establishment of distinct and dedicated cosmetic laws was a critical and fundamental choice for the industry to overcome numerous problems. As these rules explain the regulatory requirements and standards governing the import, production, and distribution of cosmetic items in India, they also provide a level of regulatory certainty that was lacking under the previous regime of medicines and cosmetics rules.

Additionally, Mr Jaiswal stated that one of the most significant advancements in the domain of regulatory digitisation that has resulted in enhanced efficiency is the simplification and shortening of the application procedure. "The Cosmetics Rules 2020 as a whole have created a new window of opportunity for the business, resulting in a reduction in procedural and regulatory difficulties. Industry has always collaborated with regulatory authorities to increase understanding of existing regulations, and the authorities have always reciprocated "'He stated.

"Cosmetic is a dynamic sector with a rapid pace of innovation and rapid changes in customer tastes," stated Dr Manas Vyas, Head, Regulatory Affairs & Operations at Colgate Palmolive (India) Ltd.